Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck'
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Medical News Today16d
Nasal vestibulitis: Is it a pimple, and what can I do about it?
In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...
Investopedia16d
Forex Market Hours: Can You Trade 7 Days a Week?
Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Robert Kelly is managing director of XTS Energy LLC, and has more than three ...
India Today20d
US FDA approves new nasal spray for depression treatment: All about it
Spravato has shown to help patients experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral antidepressants. The nasal spray works by ...
healthday21d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... in depressive symptoms as early as 24 ...
The Daily Beast21d
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report21d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults ... as early as 24 hours and at 28 days -- without ...
Newsweek21d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug ... neurotransmitter and can reduce symptoms in as little as 24 hours. Johnson & Johnson said that because there are risks of "serious adverse ...
New York Post21d
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions ... in their symptoms as early as 24 hours without the need for daily oral ...
CNN21d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...